Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franziska Meier

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
BMC Cancer|February 22, 2018
Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patientsHanna Huebner, Peter A Fasching, Walter Gumbrecht, et al.
The Journal of Molecular Diagnostics : JMD|November 1, 2019
Detection of ESR1 Mutations in Single Circulating Tumor Cells on Estrogen Deprivation Therapy but Not in Primary Tumors from Metastatic Luminal Breast Cancer PatientsAndré Franken, Ellen Honisch, Florian Reinhardt, et al.
JCO Precision Oncology|February 17, 2022
Discordance in Human Epidermal Growth Factor Receptor 2 (HER2) Phenotype Between Primary Tumor and Circulating Tumor Cells in Women With HER2-Negative Metastatic Breast CancerAmelie De Gregorio, Thomas W P Friedl, Jens Huober, et al.
Methods in Enzymology|April 27, 2025
Cupriavidus necator as a model organism for CO<sub>2</sub>-based biotechnologyHalima Aliyu Alhafiz, Federico Di Bisceglie, Hannah Pia Franziska Meier, et al.
British Journal of Cancer|February 24, 2023
Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical valueAndré Franken, Annika Kraemer, Alicia Sicking, et al.
EMBO Molecular Medicine|November 1, 2014
Molecular profiling of single circulating tumor cells with diagnostic intentionBernhard Polzer, Gianni Medoro, Sophie Pasch, et al.
Clinical Chemistry|January 4, 2024
Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical TrialTanja Fehm, Volkmar Mueller, Maggie Banys-Paluchowski, et al.
Critical Reviews in Oncology/Hematology|February 18, 2019
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paperMassimo Cristofanilli, Jean-Yves Pierga, James Reuben, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
BMC Cancer|February 22, 2018
Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patientsHanna Huebner, Peter A Fasching, Walter Gumbrecht, et al.
The Journal of Molecular Diagnostics : JMD|November 1, 2019
Detection of ESR1 Mutations in Single Circulating Tumor Cells on Estrogen Deprivation Therapy but Not in Primary Tumors from Metastatic Luminal Breast Cancer PatientsAndré Franken, Ellen Honisch, Florian Reinhardt, et al.
JCO Precision Oncology|February 17, 2022
Discordance in Human Epidermal Growth Factor Receptor 2 (HER2) Phenotype Between Primary Tumor and Circulating Tumor Cells in Women With HER2-Negative Metastatic Breast CancerAmelie De Gregorio, Thomas W P Friedl, Jens Huober, et al.
Methods in Enzymology|April 27, 2025
Cupriavidus necator as a model organism for CO<sub>2</sub>-based biotechnologyHalima Aliyu Alhafiz, Federico Di Bisceglie, Hannah Pia Franziska Meier, et al.
British Journal of Cancer|February 24, 2023
Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical valueAndré Franken, Annika Kraemer, Alicia Sicking, et al.
EMBO Molecular Medicine|November 1, 2014
Molecular profiling of single circulating tumor cells with diagnostic intentionBernhard Polzer, Gianni Medoro, Sophie Pasch, et al.
Clinical Chemistry|January 4, 2024
Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical TrialTanja Fehm, Volkmar Mueller, Maggie Banys-Paluchowski, et al.
Critical Reviews in Oncology/Hematology|February 18, 2019
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paperMassimo Cristofanilli, Jean-Yves Pierga, James Reuben, et al.
Pageof 4